Glenmark Pharmaceuticals Ltd

GLENMARK14 Jun 2024
Pharmaceuticals
+10.90 (+0.89%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in Glenmark Pharma.
Glenmark Pharmaceuticals Ltd
Pharmaceuticals
GLENMARK14 Jun 2024
+10.90 (+0.89%)
1D
1M
6M
1Y
5Y
All

Glenmark Pharma. - Share Price & Details

Lowest Today
1221.65
Highest Today
1240
Today’s Open
1223
Prev. Close
1225.25
52 Week High
1240
52 Week Low
620.05
Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
88.88%
Upper Circuit
Lower Circuit
P/E TTM
24.27
P/B Ratio
1.51
Traded Value(Cr)
0.00
EPS TTM
50.49
Book value
Dividend
0.20%

Price Performance

1.24 %
1 Wk
18.58 %
1 M
36.27 %
3 M
88.88 %
1 Y
43.18 %
YTD

Traded Volume Movement

Technical Details

Support 3
1206
Support 2
1214
Support 1
1226
Pivot Point :
1233
Resistance 1
1245
Resistance 2
1253
Resistance 3
1265

Reports

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Glenmark Pharmaceuticals Ltd
₹1,236.15(+10.90/0.89%)
1,236.15+10.9034,575.1088.8824.271.51
Astrazeneca Pharma India Ltd
₹6,458.00(+107.05/1.69%)
6,458.00+107.0515,877.3879.08106.2022.30
Cipla Ltd
₹1,565.30(+21.85/1.42%)
1,565.30+21.85124,617.3857.2733.554.45
Bliss GVS Pharma Ltd
₹106.00(+0.65/0.62%)
106.00+0.651,102.9236.6814.551.12
Amrutanjan Health Care Ltd
₹749.85(-7.00/-0.92%)
749.85-7.002,188.1028.4948.647.58
Abbott India Ltd
₹27,452.30(-160.50/-0.58%)
27,452.30-160.5058,677.2024.6548.8515.86

About Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 34575.1 crores. It has reported a sales of Rs. 2077.13 crores and a net profit of Rs. 4613.7 crores for the quarter ended December 2018. The company management includes Glenn Saldanha, Glenn Saldanha,Cheryl Pinto,V S Mani,B E Saldanha,Rajesh Desai.,Devendra Raj Mehta,Bernard Munos,Brian W Tempest,Sridhar Gorthi,Sona Saira Ramasastry,Dipankar Bhattacharjee,V R Iyer (Glenmark Pharmaceuticals Ltd) among others.
Chairman
Glenn Saldanha
Registered office
B/2 Mahalaxmi Chambers,22 Bhulabhai Desai Road,Mumbai,Maharashtra,400026
FAX :91-22-40189986
Background
Incorporation Year1977
Face Value₹1
Market Lot1

Latest News

Auto Stocks Rev Up Nifty To Another All-Time High
On Friday, Nifty 50 made a fresh all-time high of 23,490.40. The benchmark index closed 0.29% higher to 23,465.60 in the session. Eicher Motors was the top gainer while Tech Mahindra was the biggest loser. This uplift contributed positively to the market’s overall sentiment. Adani Ports also showed strong performance, marking a 2.31% increase to close at ₹1430.70.
14 Jun 2024 | 06:16 PM
Nifty bull case target at 27,100, says Prabudas Lilladher
Prabhudas Lilladher values Nifty at a 5% premium to its 15-year average PE of 20.2x, setting a bull case target of 27,102. The brokerage firm's 12-month Nifty target is 25,816, with large cap stocks like HDFC Bank, ITC, and RIL among its conviction picks. The index is currently trading at 19.2x 1-year forward EPS, with EPS CAGR expected to grow 14.9% over FY24-26.
14 Jun 2024 | 06:13 PM
Nifty bull case target at 27,100, says Prabudas Lilladher
Prabhudas Lilladher values Nifty at a 5% premium to its 15-year average PE of 20.2x, setting a bull case target of 27,102. The brokerage firm's 12-month Nifty target is 25,816, with large cap stocks like HDFC Bank, ITC, and RIL among its conviction picks. The index is currently trading at 19.2x 1-year forward EPS, with EPS CAGR expected to grow 14.9% over FY24-26.
14 Jun 2024 | 06:13 PM
✅Sensex surges 182 points at the Close; Nifty above 23,450
✅ Amid positive global cues, benchmark indices closed on a positive note today.
📢 At 3:30 PM, the Sensex improved by 23,465.60 points or 0.24% at 76,992.77, and the Nifty was up 66.70 points or 0.29% at 23,465.60.
📊Among sectoral, Nifty Auto (⬆️1.30%) turned out to be the best performer while Nifty IT (⬇️0.87%) saw considerable selling.
14 Jun 2024 | 03:38 PM
70% of Nifty Realty stocks delivered multibagger returns in one year
The Nifty Realty index surged 15% in eight trading sessions, reaching a new peak of 1,134 points, with a 44% year-to-date gain. All 10 constituents gained between 20% and 121% year-to-date, with Sobha leading the pack with a 290% gain. The sector's stellar performance is driven by robust sales growth, new developments, and improving financial indicators.
14 Jun 2024 | 02:32 PM

How to buy Glenmark Pharma. shares on nse?

To buy Glenmark Pharma. shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Glenmark Pharma. share price today?

The Glenmark Pharma. shares price on nse is Rs.1236.15 today.

What is the market cap of Glenmark Pharma. shares on BSE ?

The company has a market capitalization of Rs.34575.10Cr

What is the PE & PB ratio of Glenmark Pharma. shares ?

PE is 24.27 and PB is 1.51

What is the 52 Week High and Low of Glenmark Pharma. shares?

Glenmark Pharma. stock price high: Rs.1240 Glenmark Pharma. stock price low: Rs.620.05

How has the GLENMARK share price performed in the past year?

In April 2022, the huge pharmaceutical GLENMARK’s share price was in the region of Rs. 478. By June, it had dipped to the late 300 levels and never significantly went up till November. Highs were felt in December, and February 2023, and now the stock is at the 448 level. 

Does GLENMARK pay dividends to its shareholders?

GLENMARK has a consistent track record of paying dividends to its loyal shareholders. In the recent past, the company has paid only final dividends, but interim dividends have been paid in the past as well. 

What is the dividend yield of GLENMARK?

The dividend yield of GLENMARK is 0.56% (March 2022). 

How does GLENMARK compare to its competitors in terms of share price?

Compared to popular competitors of GLENMARK, like Sun Pharma, Dr Reddy’s Labs, CIPLA, Torrent Pharma, Abbott India and others, the company’s share price is low at the moment (March 2023). Most of these companies have their share prices in the thousands, or late hundreds, whereas GLENMARK seems firmly poised on the mid-hundred mark. 

What is the company's debt-to-equity ratio?

The company’s debt-to-equity ratio is 0.22. 

What is the company's revenue and net income?

The revenue of GLENMARK is Rs. 3,463 crores (Q3 FY 2022-23)  and the net income is Rs. 291 crores (December 2022). 

How long has GLENMARK been in business?

GLENMARK started its foray into the pharmaceutical business with “Candid Cream”, a key dermatological drug, even in use now. The company started its business in 1977, headed by its Founder Emeritus, the late Gracias Saldanha. 

What is the company's history of share price performance?

The share price of GLENMARK has been somewhat stable in the last 4-5 years, not showing much volatility as other pharma stocks have. In 2018, the share was in the region of the 500 mark, peaking at nearly 700 in 2019. Then, with a gradual and slow downward movement, it dipped to the region of 199 in 2020, only to slowly rise to 662 in 2021. Since then, it has been in the range of between 400-500 and is steady now.